Beverly Hills 12/4/2009 4:11:04 AM
News / Business

New CFO for Jazz Pharmaceuticals

Finance World News Update by EQUITIES Magazine

Drug developer Jazz Pharmaceuticals Inc. announced today it has appointed Kathryn E. Falberg as chief financial officer.

Most recently CFO of ARCA biopharma Inc., Falberg had also been an investor and consultant.

Shares of Jazz fell 7 cents to $7.52 in afternoon trading.

About EQUITIES:

Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.

Sign up for a free one-year subscription to EQUITIES Magazine